Post #3243134

Promising news on BBC site about a breakthrough ovarian #cancer treatment becoming available on our health service. Monoclonal Antibody (MAB) regimens aren't a new phenomenon overall. I'm guessing their already promising trajectory is advancing in efficacy & reducing collateral damage to non-cancerous cells. My chemo 24 years ago didn't involve MAB but, if and when I fall out of remission & my NHL returns, maybe I too will then receive MAB. https://www.bbc.co.uk/news/articles/ce8p57y35lzo